Optiscan Imaging (OIL.AX) Stock Price

Optiscan Imaging Price

ASX·CLOSED
0.14AUD-0.01 (-6.90 %)
Market closed

Revenue at Optiscan Imaging has contracted by 8.1% per year over the past 19 years to 952,000.00 AUD. Optiscan Imaging's net margin stands at -663.0%, down from -239.1% several years earlier. The stock trades about 75% above its 52-week low.

Optiscan Imaging stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Optiscan Imaging over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Optiscan Imaging stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Optiscan Imaging's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Optiscan Imaging Stock Price History
DateOptiscan Imaging Price
7/21/20260.14 AUD
7/20/20260.15 AUD
7/17/20260.16 AUD
7/16/20260.16 AUD
7/15/20260.16 AUD
7/14/20260.16 AUD
7/13/20260.16 AUD
7/10/20260.16 AUD
7/9/20260.15 AUD
7/8/20260.16 AUD
7/7/20260.15 AUD
7/6/20260.14 AUD
7/3/20260.14 AUD
7/2/20260.14 AUD
7/1/20260.13 AUD
6/30/20260.12 AUD
6/29/20260.13 AUD
6/26/20260.13 AUD
6/25/20260.13 AUD
6/24/20260.12 AUD
6/23/20260.12 AUD
6/22/20260.13 AUD
6/19/20260.13 AUD
6/18/20260.13 AUD
6/17/20260.13 AUD
6/16/20260.12 AUD
6/15/20260.12 AUD
6/12/20260.13 AUD
6/11/20260.13 AUD
6/10/20260.13 AUD
6/9/20260.14 AUD
6/5/20260.14 AUD
6/4/20260.13 AUD
6/3/20260.13 AUD
6/2/20260.14 AUD
6/1/20260.13 AUD
5/29/20260.12 AUD
5/28/20260.12 AUD
5/27/20260.12 AUD
5/26/20260.11 AUD
5/25/20260.11 AUD
5/22/20260.11 AUD
5/21/20260.10 AUD
5/20/20260.11 AUD
5/19/20260.11 AUD
5/18/20260.10 AUD
5/15/20260.10 AUD
5/14/20260.10 AUD
5/13/20260.10 AUD
5/12/20260.11 AUD
5/11/20260.10 AUD
5/8/20260.10 AUD
5/7/20260.11 AUD
5/6/20260.11 AUD
5/5/20260.11 AUD
5/4/20260.11 AUD
5/1/20260.11 AUD
4/30/20260.11 AUD
4/29/20260.10 AUD
4/28/20260.10 AUD
4/27/20260.11 AUD
4/24/20260.11 AUD
4/23/20260.11 AUD
4/22/20260.11 AUD
4/21/20260.11 AUD
4/20/20260.11 AUD
4/17/20260.12 AUD
4/16/20260.12 AUD
4/15/20260.11 AUD
4/14/20260.12 AUD
4/13/20260.12 AUD
4/10/20260.12 AUD
4/9/20260.12 AUD
4/8/20260.10 AUD
4/7/20260.10 AUD
4/2/20260.10 AUD
3/27/20260.10 AUD
3/26/20260.10 AUD
3/25/20260.10 AUD
3/24/20260.10 AUD
3/23/20260.08 AUD
3/20/20260.09 AUD
3/19/20260.09 AUD
3/18/20260.09 AUD
3/17/20260.09 AUD
3/16/20260.09 AUD
3/13/20260.09 AUD
3/12/20260.10 AUD
3/11/20260.09 AUD
3/10/20260.10 AUD
3/9/20260.09 AUD
3/6/20260.09 AUD
3/5/20260.09 AUD
3/4/20260.09 AUD
3/3/20260.09 AUD
3/2/20260.09 AUD
2/27/20260.09 AUD
2/26/20260.08 AUD
2/25/20260.08 AUD
2/24/20260.08 AUD
2/23/20260.09 AUD
2/20/20260.09 AUD
2/19/20260.09 AUD
2/18/20260.09 AUD
2/17/20260.09 AUD
2/16/20260.09 AUD
2/13/20260.09 AUD
2/12/20260.09 AUD
2/11/20260.09 AUD
2/10/20260.09 AUD
2/9/20260.09 AUD
2/6/20260.09 AUD
2/5/20260.09 AUD
2/4/20260.09 AUD
2/3/20260.09 AUD
2/2/20260.09 AUD
1/30/20260.10 AUD
1/29/20260.09 AUD
1/28/20260.09 AUD
1/27/20260.09 AUD
1/23/20260.09 AUD
1/22/20260.09 AUD
1/21/20260.09 AUD
1/20/20260.09 AUD
1/19/20260.10 AUD
1/16/20260.09 AUD
1/15/20260.09 AUD
1/13/20260.09 AUD
1/12/20260.10 AUD
1/9/20260.10 AUD
1/8/20260.09 AUD
1/7/20260.10 AUD
1/6/20260.10 AUD
1/5/20260.10 AUD
1/2/20260.10 AUD
12/31/20250.10 AUD
12/30/20250.10 AUD
12/29/20250.10 AUD
12/24/20250.11 AUD
12/23/20250.10 AUD
12/22/20250.11 AUD
12/19/20250.11 AUD
12/18/20250.10 AUD
12/16/20250.11 AUD
12/15/20250.10 AUD
12/12/20250.11 AUD
12/11/20250.11 AUD
12/10/20250.10 AUD
12/9/20250.11 AUD
12/8/20250.11 AUD
12/5/20250.11 AUD
12/4/20250.11 AUD
12/3/20250.10 AUD
12/2/20250.12 AUD
12/1/20250.11 AUD
11/28/20250.10 AUD
11/27/20250.10 AUD
11/26/20250.10 AUD
11/25/20250.10 AUD
11/24/20250.10 AUD
11/21/20250.10 AUD
11/20/20250.11 AUD
11/19/20250.11 AUD
11/18/20250.12 AUD
11/17/20250.12 AUD
11/14/20250.12 AUD
11/13/20250.13 AUD
11/12/20250.12 AUD
11/11/20250.12 AUD
11/10/20250.13 AUD
11/7/20250.12 AUD
11/6/20250.11 AUD
11/5/20250.12 AUD
11/4/20250.11 AUD
11/3/20250.12 AUD
10/31/20250.13 AUD
10/30/20250.12 AUD
10/29/20250.12 AUD
10/28/20250.12 AUD
10/27/20250.11 AUD
10/24/20250.11 AUD
10/23/20250.11 AUD
10/22/20250.13 AUD
10/21/20250.12 AUD
10/20/20250.12 AUD
10/17/20250.13 AUD
10/16/20250.13 AUD
10/15/20250.14 AUD
10/14/20250.13 AUD
10/13/20250.12 AUD
10/10/20250.13 AUD
10/9/20250.12 AUD
10/8/20250.13 AUD
10/7/20250.13 AUD
10/6/20250.13 AUD
10/3/20250.12 AUD
10/2/20250.12 AUD
10/1/20250.09 AUD
9/30/20250.09 AUD
9/29/20250.09 AUD
9/26/20250.08 AUD
9/25/20250.08 AUD
9/24/20250.08 AUD
9/23/20250.08 AUD
9/22/20250.08 AUD
9/19/20250.08 AUD
9/18/20250.09 AUD
9/17/20250.08 AUD
9/16/20250.09 AUD
9/15/20250.09 AUD
9/12/20250.08 AUD
9/11/20250.08 AUD
9/10/20250.09 AUD
9/9/20250.09 AUD
9/8/20250.09 AUD
9/5/20250.09 AUD
9/4/20250.09 AUD
9/2/20250.10 AUD
9/1/20250.09 AUD
8/29/20250.09 AUD
8/28/20250.09 AUD
8/27/20250.09 AUD
8/26/20250.08 AUD
8/25/20250.08 AUD
8/22/20250.08 AUD
8/21/20250.08 AUD
8/20/20250.08 AUD
8/19/20250.08 AUD
8/18/20250.08 AUD
8/15/20250.08 AUD
8/14/20250.08 AUD
8/13/20250.09 AUD
8/12/20250.09 AUD
8/11/20250.09 AUD
8/8/20250.10 AUD
8/7/20250.09 AUD
8/6/20250.10 AUD
8/5/20250.10 AUD
8/4/20250.09 AUD
8/1/20250.11 AUD
7/31/20250.11 AUD
7/30/20250.11 AUD
7/28/20250.11 AUD
7/25/20250.11 AUD
7/24/20250.11 AUD
Access this data via the Eulerpool API
Get Free API Key

Optiscan Imaging Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
2.20 M AUD
-1.99 M AUD
-2.04 M AUD
Jan 1, 2019
1.05 M AUD
-2.34 M AUD
-2.34 M AUD
Jan 1, 2020
1.19 M AUD
-1.70 M AUD
-1.77 M AUD
Jan 1, 2021
889,500.00 AUD
-2.36 M AUD
-2.13 M AUD
Jan 1, 2022
1.01 M AUD
-4.23 M AUD
-4.23 M AUD
Jan 1, 2023
1.68 M AUD
-4.35 M AUD
-4.35 M AUD
Jan 1, 2024
1.16 M AUD
-6.58 M AUD
-6.06 M AUD
Jan 1, 2025
952,000.00 AUD
-6.60 M AUD
-6.31 M AUD

Optiscan Imaging Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 23, 2026, 7:29 PM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
1.00––––––1.002.001.001.00–1.001.001.00–
-50.00–––––––100.00-50.00––––––
100.00––––––100.0050.00100.00100.00–-100.00100.00100.00–
1.001.001.001.001.001.001.001.001.001.001.001.00-1.001.001.001.00
-2.00–-2.00–-1.00-1.00-1.00-2.00-1.00-2.00-1.00-2.00-4.00-4.00-6.00-6.00
-200.00––––––-200.00-50.00-200.00-100.00–-400.00-400.00-600.00–
-1.00–-2.00–-1.00-1.00-1.00-2.00-2.00-2.00-1.00-2.00-4.00-4.00-6.00-6.00
-83.33––––––100.00––-50.00100.00100.00–50.00–
122.75129.71132.12156.06163.73193.84221.00333.53414.92433.71484.08583.16631.11640.43828.58841.06
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Optiscan Imaging generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Optiscan Imaging retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Optiscan Imaging's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Optiscan Imaging has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Optiscan Imaging's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Optiscan Imaging stock margins

The Optiscan Imaging margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Optiscan Imaging. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Optiscan Imaging.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
73.07 %
-90.68 %
-92.61 %
Jan 1, 2019
-5.17 %
-222.93 %
-222.93 %
Jan 1, 2020
66.12 %
-143.18 %
-148.27 %
Jan 1, 2021
-16.59 %
-265.67 %
-239.09 %
Jan 1, 2022
-139.85 %
-417.78 %
-417.87 %
Jan 1, 2023
67.11 %
-258.92 %
-258.99 %
Jan 1, 2024
54.47 %
-569.78 %
-524.45 %
Jan 1, 2025
50.41 %
-693.32 %
-663.03 %

Optiscan Imaging Stock Revenue, EBIT, Earnings per Share

The Optiscan Imaging earnings per share therefore indicates how much revenue Optiscan Imaging has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.01 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2019
0.00 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2020
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2021
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2022
0.00 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2023
0.00 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2024
0.00 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2025
0.00 AUD
-0.01 AUD
-0.01 AUD

Optiscan Imaging business model & stock analysis

Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging.

Optiscan Imaging SWOT Analysis

Strengths

1. Cutting-edge imaging technology: Optiscan Imaging Ltd possesses advanced imaging technology, allowing them to provide high-resolution and accurate imaging solutions.

2. Strong patent portfolio: The company holds a significant number of patents, providing them with a competitive advantage and protecting their innovative products.

3. Established brand reputation: Optiscan Imaging Ltd has built a solid reputation for delivering reliable and high-quality imaging products, earning trust from customers and industry experts.

Weaknesses

1. Limited market presence: Despite their strengths, Optiscan Imaging Ltd faces challenges in terms of market reach, particularly in expanding their customer base beyond their current target segments.

2. Dependency on key suppliers: The company relies heavily on a few suppliers for critical components, which exposes them to potential disruptions in the supply chain.

3. Relatively small R&D budget: Optiscan Imaging Ltd's R&D budget is comparatively smaller than some competitors, limiting their ability to invest in new product development and innovation.

Opportunities

1. Increasing demand for medical imaging: The healthcare industry's growing need for advanced imaging solutions presents an opportunity for Optiscan Imaging Ltd to expand its market share and revenue.

2. Emerging markets: Optiscan Imaging Ltd can explore untapped markets in developing regions, where the adoption of advanced medical technology is on the rise.

3. Partnerships and collaborations: Collaborating with research institutions, medical centers, and industry partners can enhance Optiscan Imaging Ltd's research capabilities and open doors to new technological advancements.

Threats

1. Intense competition: Optiscan Imaging Ltd operates in a highly competitive market with both established players and new entrants, increasing the pressure to differentiate and innovate.

2. Evolving regulations: Changing regulations and compliance requirements in the healthcare industry can pose challenges and increase the complexity of product development and market entry.

3. Technological advancements: Rapid advancements in imaging technology may require substantial investments to keep up with the pace of innovation, potentially straining Optiscan Imaging Ltd's resources.

Optiscan Imaging Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Optiscan Imaging historical P/E ratio, EBIT multiple, and P/S ratio

Optiscan Imaging annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Optiscan Imaging shares outstanding

The number of shares of Optiscan Imaging was 841.06 M in 2025. This indicates how many shares Optiscan Imaging is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
414.92 M Stocks
Jan 1, 2019
433.71 M Stocks
Jan 1, 2020
484.08 M Stocks
Jan 1, 2021
583.16 M Stocks
Jan 1, 2022
631.11 M Stocks
Jan 1, 2023
640.43 M Stocks
Jan 1, 2024
828.58 M Stocks
Jan 1, 2025
841.06 M Stocks
Price targets and forecasts for Optiscan Imaging are not yet available.

Optiscan Imaging shareholder structure

% Name
27.61018%
Peters Investments Pty. Ltd.
Peters Investments Pty. Ltd.
18.44220%
Clermont Group
Clermont Group
5.17204%
Ibsen Pty. Ltd.
Ibsen Pty. Ltd.
1.98074%
Harech Pty. Ltd.
Harech Pty. Ltd.
1.54567%
Graham (Chris)
Graham (Chris)
1.05819%
Farah (Camile)
Farah (Camile)

Optiscan Imaging Executives and Management Board

PF

Prof. Camile Farah

Chief Executive Officer, Managing Director, Executive Director · since 2021

Compensation408,966.00 AUD
RC

Mr. Robert Cooke

(62)

Non-Executive Chairman of the Board

Compensation252,009.00 AUD
KB

Ms. Karen Borg

Non-Executive Director

Compensation148,657.00 AUD
RS

Mr. Ron Song

Non-Executive Director

Compensation47,666.00 AUD
BF

Mr. Brendan Fafiani

Chief Operating Officer

Optiscan Imaging Supply Chain

Optiscan Imaging Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#Name1M3M6M1Y2YTrend
1
Carl Zeiss Meditec
Supplier
0.33
0.13
0.80
0.45
0.63
2
HSBC Holdings
Supplier
0.31
0.08
-0.76
-0.64
0.32
#Name1M3M6M1Y2YTrend
1
Ramsay Health Care
Supplier
-0.54
-0.02
0.18
-0.09
0.10

Frequently asked questions about Optiscan Imaging

The business model of Optiscan Imaging Ltd focuses on developing and commercializing advanced medical imaging technologies. The company specializes in the design and manufacture of confocal laser endomicroscopes, which are used in various medical applications. Optiscan Imaging aims to improve the diagnosis and treatment of diseases through their innovative imaging solutions. By leveraging their expertise in advanced imaging technologies, the company aims to provide healthcare professionals with high-quality and real-time cellular imaging during medical procedures. Optiscan Imaging Ltd's business model is centered around offering cutting-edge medical imaging technologies that deliver precise and detailed cellular imaging for improved patient outcomes.

All fundamentals and in-depth analysis of Optiscan Imaging

Our stock analysis for Optiscan Imaging stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Optiscan Imaging. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Optiscan Imaging Stock
Optiscan Imaging Revenue→
Optiscan Imaging Stock
Optiscan Imaging Net Income→
Optiscan Imaging Stock
Optiscan Imaging P/E→
Optiscan Imaging Stock
Optiscan Imaging P/S→
Optiscan Imaging Stock
Optiscan Imaging EBIT→
Optiscan Imaging Stock
Optiscan Imaging Dividend→
Optiscan Imaging Stock
Optiscan Imaging Directors Dealings→
Optiscan Imaging Stock
Optiscan Imaging Stocks→
Optiscan Imaging Stock
Optiscan Imaging Market capitalization→
Optiscan Imaging Stock
Optiscan Imaging Debt→
Optiscan Imaging Stock
Optiscan Imaging Liabilities→
Optiscan Imaging Stock
Optiscan Imaging Equity→
Optiscan Imaging Stock
Optiscan Imaging AAQS→
Optiscan Imaging Stock
Optiscan Imaging Employees→
Optiscan Imaging Stock
Optiscan Imaging ROE→
Optiscan Imaging Stock
Optiscan Imaging ROA→
Optiscan Imaging Stock
Optiscan Imaging ROCE→
Optiscan Imaging Stock
Optiscan Imaging News→
Optiscan Imaging Stock
Optiscan Imaging Analyst Price Targets→

Health Stocks

Optomed OyjOptiPharm CoOptus Pharmaceutical CoOption Care HealthOpus GeneticsOptimizeRxOragenicsOPKO HealthOramed PharmaceuticalsOPC Pharmaceutical JSCOraSure TechnologiesOnyx HealthcareAll Stocks A–Z →